Login / Signup

Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression.

Inés Pérez-SancristóbalEduardo de la FuenteMaría Paula Álvarez-HernándezKissy Guevara-HoyerConcepción MoradoCristina Martínez-PradaDalifer Freites-NuñezVirginia VillaverdeMiguel Fernández-ArqueroBenjamín Fernández GutiérrezSilvia Sánchez-RamónGloria Candelas
Published in: Biomedicines (2023)
Even though the beneficial protective effects against infections of TIbV progressively decreased, they remained low for up to 3 years, with significantly reduced infections compared to the year prior to vaccination, further supporting a long-term benefit of TIbV in this setting. Moreover, an absence of infections was observed in almost half of patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • patient reported outcomes
  • patient reported
  • drug induced